InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c

InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Lands' End (LE) Tops Q2 EPS by 1c
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance